Table 3. Incidence of all grades and high-grade hyperglycaemia in cases (PAM inhibitors) and controls (non-PAM inhibitors).

	All grades hyperglycaemia				Grade 3 and 4 hyperglycaemia
	Total	No	Yes	P-valuea	No	Yes	P-valuea
Cases n (%)	387 (100)	52 (13.4)	335 (86.6)	0.129	361 (93.3)	26 (6.7)	0.005
95% CI	–	10.4%–17.2%	82.8%–89.6%		90.3%–95.4%	4.6%–9.7%
Controls n (%)	109 (100)	21 (19.3)	88 (80.7)		109 (100)	0 (0)
95% CI		13.0%–27.7%	72.3%–87.0%		96.6%–100%	0%–3.4%

Abbreviation: CI=confidence interval.

^aχ²-test.